APA (7th ed.) Citation

Luxford, J. C., Casey, C. E., Roberts, P. A., & Irving, C. A. (2024). Iron deficiency and anemia in pediatric dilated cardiomyopathy are associated with clinical, biochemical, and hematological markers of severe disease and adverse outcomes. The Journal of heart and lung transplantation, 43(3), 379. https://doi.org/10.1016/j.healun.2023.11.014

Chicago Style (17th ed.) Citation

Luxford, Jack C., Charlene E. Casey, Philip A. Roberts, and Claire A. Irving. "Iron Deficiency and Anemia in Pediatric Dilated Cardiomyopathy Are Associated with Clinical, Biochemical, and Hematological Markers of Severe Disease and Adverse Outcomes." The Journal of Heart and Lung Transplantation 43, no. 3 (2024): 379. https://doi.org/10.1016/j.healun.2023.11.014.

MLA (9th ed.) Citation

Luxford, Jack C., et al. "Iron Deficiency and Anemia in Pediatric Dilated Cardiomyopathy Are Associated with Clinical, Biochemical, and Hematological Markers of Severe Disease and Adverse Outcomes." The Journal of Heart and Lung Transplantation, vol. 43, no. 3, 2024, p. 379, https://doi.org/10.1016/j.healun.2023.11.014.